10 mg retatrutide (10mg) – Vitanx Research Retatrutide Revytal 40mg UK |

Diabetic kidney disease

Acute Kidney Injury On the FDA label for Ozempic, acute kidney injury and worsening of chronic renal failure is listed as a potential adverse reaction

These check-ups allow for adjustments to the treatment plan as necessary to ensure optimal control of diabetes

Retatrutide is currently in Phase 3 clinical trials, which means it successfully passed Phase 1 (safety in healthy volunteers) and Phase 2 (efficacy and safety in target population)

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

This is a positive sign that the reset achieved its goal